Novavax
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novavax and other ETFs, options, and stocks.About NVAX
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines.
CEOJohn C.s Jacobs
CEOJohn C.s Jacobs
Employees952
Employees952
HeadquartersGaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded1987
Founded1987
Employees952
Employees952
NVAX Key Statistics
Market cap965.34M
Market cap965.34M
Price-Earnings ratio2.33
Price-Earnings ratio2.33
Dividend yield—
Dividend yield—
Average volume10.97M
Average volume10.97M
High today$6.28
High today$6.28
Low today$5.87
Low today$5.87
Open price$6.20
Open price$6.20
Volume8.53M
Volume8.53M
52 Week high$23.86
52 Week high$23.86
52 Week low$5.01
52 Week low$5.01
NVAX News
TipRanks 6d
Novavax sees ‘pathway’ to resolving FDA issues for Covid approval, Reuters saysNovavax (NVAX) says that it sees a pathway to resolving issues with the FDA for full approval of its Covid vaccine shot, Reuters’ Sriparna Roy reports. The comp...
Benzinga 6d
COVID Vaccine Maker Novavax Stock Soars 16% - Here's WhyOn Thursday, Novavax Inc. NVAX reported first-quarter 2025 sales of $667 million, compared to $94 million a year ago, beating the consensus of $343.85 million....
Benzinga 7d
Thursday's Top 5 Trending Stocks: What's Going On With D-Wave, Novavax, Carvana?D-Wave Quantum Inc. QBTS, Asset Entities, Inc. ASST, Alphabet, Inc. GOOG GOOGL, Novavax, Inc. NVAX and Carvana Co. CVNA are the top five trending tickers on Sto...
Analyst ratings
57%
of 7 ratingsBuy
57.1%
Hold
28.6%
Sell
14.3%
More NVAX News
Seeking Alpha 7d
Novavax rises after massive Q1 beat, guidance raiseNovavax (NASDAQ:NVAX) shares climbed ~35% in the premarket on Thursday after the COVID-19 vaccine maker lifted its full-year revenue outlook and reported Q1 202...
People also own
Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.